je.st
news
AEterna Zentaris' (AEZS) Buy Rating Reiterated at Canaccord Genuity
2016-04-05 02:28:39| Biotech - Topix.net
's stock had its "buy" rating reissued by analysts at Canaccord Genuity in a research report issued on Monday, MarketBeat.Com reports. They presently have a $9.00 price target on the biopharmaceutical company's stock, down from their prior price target of $13.00.
Tags: buy
rating
aeterna
buy rating
Category:Biotechnology and Pharmaceuticals